Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alfa vs daily recombinant FSH for controlled ovarian stimulation in IVF/ICSI (≤60 kg women)
2006-003811-36Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of corifollitropin alfa in superovulation (2 arms), sponsored by Organon & Co. Primary endpoint: Number of oocytes retrieved. Started Nov 2006; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
superovulation
Beyond the preview
Go deeper on 2006-003811-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003811-36.